• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Researchers find genes, corresponding proteins that may lead to new depression treatments

Bioengineer by Bioengineer
April 12, 2021
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Lisa Pessin

Using an innovative protein-based approach, researchers at the Atlanta Veterans Affairs Medical Center and nearby Emory University have found genes and corresponding proteins that could point the way to new depression treatments.

Using a proteome-wide association study (PWAS) that integrated genome-wide association study (GWAS) data with human brain proteomic and genetic data, researchers have identified 19 genes that may lead to depression by altering brain protein levels. They also pinpointed 25 such proteins that offer promise as potential targets for new depression treatments.

The researchers detail their approach and findings in April 2021 in the journal Nature Neuroscience.

Depression is a common condition, but current treatments are ineffective for many people with the mental illness. This research sets the stage for finding new drugs to treat the illness by identifying important gene-protein pairs that likely contribute to the cause of depression and could serve as promising targets for future studies, according to lead researcher Dr. Aliza Wingo, a psychiatrist at the Atlanta VA. She’s also an associate professor at Emory University.

Wingo works with Dr. Thomas Wingo, the first author of the study, at their joint laboratory at the Atlanta VA and Emory. The lab focuses on understanding the genetic basis of brain illnesses. They collaborated on the study with investigators at Emory’s Center of Neurodegenerative Disease.

In seeking new therapies, the research team, with support from VA and the National Institutes of Health, aimed to identify brain proteins that likely cause depression. The team hypothesized that genetic variants influence depression by altering levels of certain brain proteins.

Genome-wide association studies played a key role in the research but were not sufficient by themselves, explained Thomas Wingo. GWAS is an important tool for its ability to spot variations associated with medical conditions, including depression, but the genome scans do not shed light on how genetic variations translate into increased disease risk. So the study design combined GWAS and human brain proteomic data toward answering the question, how can variations in brain protein levels explain some of the inherited risk for depression?

By examining proteins–which are the final products of gene expression and the main functional components of cells–PWAS can help elucidate the biological mechanisms underlying depression. The approach can importantly supplement information from GWAS by finding changes in the way a protein is being expressed in a normal gene versus a variant. Despite proteins’ promise as biological informants, and in spite of the fact that proteins make up the bulk of drug targets and biomarkers, this study was conspicuous among depression studies for its direct look at proteins.

It was this rare scientific method–using the “largest and deepest reference human brain proteomes and summary statistics from the latest GWAS of depression,” according to the authors–that allowed the researchers to identify the total of 25 proteins of interest, 20 of which prior GWAS studies did not peg as implicated in depression.

As for the 19 genes they homed in on, the researchers determined they “contribute to depression pathogenesis through modulating their brain protein abundance.” The brain protein fluctuations detected by uniting GWAS and human brain proteomic data are likely among the earlier biological changes in depression and may predispose a person to the illness, said Aliza Wingo, making the findings particularly compelling in terms of therapeutic potential.

Follow-up research, including tests in model systems, is crucial to further examine the identified genes’ possible roles in depression and to seek additional implicated genes and proteins, the study authors said. The provocative suggestion that the implicated proteins appear to contribute to the inherited risk of depression has spurred ongoing work at the Wingos’ lab.

“We are very excited to continue to work on these promising targets in our lab but caution that the road leading to new drugs is long and difficult,” said Thomas Wingo, noting another clinical hope based on this area of study: “We take heart that these findings could also prove useful as biomarkers for depressive symptoms. An effective biomarker–like hemoglobin A1C for diabetes–could help with diagnosis and management of depression.”

###

Media Contact
Gregory Kendall
[email protected]

Original Source

http://www.research.va.gov/currents/0421-New-Brain-Proteins-Suspected-of-Causing-Depression.cfm

Related Journal Article

http://dx.doi.org/10.1038/s41593-021-00832-6

Tags: CollaborationDepression/AngerDrugsMedicine/HealthMental HealthPharmaceutical SciencesResearch/Development
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Selective Arylating Uncommon C–F Bonds in Polyfluoroarenes

October 4, 2025
Building Larger Hydrocarbons for Optical Cycling

Building Larger Hydrocarbons for Optical Cycling

October 4, 2025

Scientists Discover How Enzymes “Dance” During Their Work—and Why It Matters

October 4, 2025

Electron Donor–Acceptor Complexes Enable Asymmetric Photocatalysis

October 4, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    92 shares
    Share 37 Tweet 23
  • New Insights Suggest ALS May Be an Autoimmune Disease

    71 shares
    Share 28 Tweet 18
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Imaging Techniques and Healing Markers in Fracture Aging

cDC3s Impair Anti-TNF-α Therapy in Ulcerative Colitis

Revolutionary Memory Network Models Ionic-Electronic Interactions

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.